GIVAUDAN-ROURE WILLING TO DO "LIMITED" PARSOL 1789 SAFETY TRIAL
This article was originally published in The Tan Sheet
Executive Summary
GIVAUDAN-ROURE WILLING TO DO "LIMITED" PARSOL 1789 SAFETY TRIAL in order to obtain monograph status, Givaudan-Roure outside counsel Edward Basile of the Washington, D.C. firm King & Spalding indicated at a May 11 "OTC feedback" meeting with FDA. To address FDA's concerns with the ingredient's safety, Basile said Givaudan- Roure "would develop some limited safety testing in humans" for the LTVA sunscreen.